36 results about "Actinotherapy" patented technology

A light therapy device (40) for delivering light energy to a portion of a patient's body comprises a light source (115). The light source comprises one or more light emitters (122) for providing input light. A light coupling means (80) directs the input light into a light guide (140). A flexible optically transparent light guide material comprises the light guide. A light extraction means (75) is applied to a surface of the light guide material. The light extraction means is positioned to provide light therapy treatment to one or more localized areas of the patient's body. A control means controls a light dosage relative to intensity, wavelength, modulation frequency, repetition, and timing of treatments.

A light source apparatus including light spectrum-converting materials that emit light primarily over large portions of the 360 nm-480 nm and the 590-860 nm spectral range is provided. This apparatus provides a cooled, high-luminance, high-efficiency light source that can provide a broader spectrum of light within these spectral ranges than has been cost-practical by using many different dominant peak emission LEDs. Up to 15% of the output radiant power may be in the spectral range 350-480 nm in one embodiment of this device, unless a specific separate source and lamp operating mode is provided for the violet and UV. Control methods for light exposure dose based on monitoring and controlling reflected or backscattered light from the illuminated surface and new heat management methods are also provided. This flexible or rigid light source may be designed into a wide range of sizes or shapes that can be adjusted to fit over or around portions of the bodies of humans or animals being treated, or mounted in such a way as to provide the special spectrum light to other materials or biological processes. This new light source can be designed to provide a cost-effective therapeutic light source for photodynamic therapy, intense pulsed light, for low light level therapy, diagnostics, medical and other biological applications as well as certain non-organic applications.

Light is administered during photodynamic therapy (PDT) for an extended period of time at a plurality of sites distributed within the abnormal tissue of a tumor. A clinical study has shown that a substantially greater volume of abnormal tissue in a tumor is destroyed by the extended administration of light therapy from a plurality of probes than would have been expected based upon the teaching of the prior art. In this process, a plurality of light emitting optical fibers or probes are deployed in a spaced-apart array. After a photoreactive agent is absorbed by the abnormal tissue, the light therapy is administered for at least three hours. The greater volume of necrosis in the tumor is achieved due to one or more concomitant effects, including: the inflammation of damaged abnormal tissue and resultant immunological response of the patient's body; the diffusion and circulation of activated photoreactive agent outside the expected fluence zone, which is believed to destroy the abnormal tissue; a retrograde thrombosis or vascular occlusion outside of the expected fluence zone; and, the collapse of the vascular system that provides oxygenated blood to portions of the tumor outside the expected fluence zone. In addition, is possible that molecular oxygen diffusing and circulating into the expected fluence zone is converted to singlet oxygen during the extended light therapy, causing a gradient of hypoxia and anoxia that destroys the abnormal tissue outside the expected fluence zone.

Apparatus and methods for treating psychiatric disorders, mood disorders and circadian rhythm disorders with a multi-stage light protocol are disclosed. The presently disclosed multi-stage light protocol provides a synergistic treatment including up to 4 types of therapies: bright light therapy, extended sleep deprivation therapy, dawn simulation therapy and short to medium wavelength light therapy. According to some embodiments, the first stage of the protocol includes a first time window of 20 minutes during which, for a majority of the time, the light intensity is between 50 lux and 2000 lux. According to some embodiments, the second stage of the protocol includes a second time window of at least 90 minutes during which, for every 10 minute period within the second time window, for a majority of the time, the light intensity is exceeds 100 lux. According to some embodiments, the third stage of the protocol includes a third time window of 60 minutes during which, for a majority of the time, the light intensity exceeds 2000 lux In some embodiments, the light is provided by apparatus including a plurality of LEDs. Typically, the light includes white light having a broad spectrum. In some embodiments, the light further includes light having a medium wavelength, for example, wavelengths between 520 nm and 535 nm.

Methods, devices and systems for delivering light therapy to human or non-human animal subjects. Included are shapeable light therapy devices which are formable into different shapes suitable for delivery of therapeutic light to different regions of the subject's body and will retain the desired shape without a need for the use of a strap or other shape-retaining apparatus. Also included are light therapy devices that, in at least some modes of operation, deliver light that is not visible to the human eye and which include indicator(s) to indicate to a user and / or to the subject being treated when non-visible light is actually being emitted.

A light-emitting, antimicrobial tuber, instrument or catheter includes a thin, flexible tube having an optically transparent wall; and a light transmitter configured and arranged to emit light through the tube, which may be ultraviolet C (UVC) irradiation, photodynamic therapy (PDT), violet-blue light therapy, and other light-based therapies. In one embodiment, violet-blue light from 400-500 nm in wavelength, such as 405 nm, for instance, is used. The device is used on a patient and a therapeutic amount of light is administered to the patient, thereby reducing the risk of infections being transmitted from the instrument, tube or catheter to the patient, generally. The device may be configured for use in the urinary tract or as intravascular, and may be indwelling or temporary. Light may be administered for the duration of use or another time period effective to halt, inhibit, or reduce microbial or fungal growth.

Methods, devices and systems for delivering light therapy to human or non-human animal subjects. Included are shapeable light therapy devices which are formable into different shapes suitable for delivery of therapeutic light to different regions of the subject's body and will retain the desired shape without a need for the use of a strap or other shape-retaining apparatus. Also included are light therapy devices that, in at least some modes of operation, deliver light that is not visible to the human eye and which include indicator(s) to indicate to a user and / or to the subject being treated when non-visible light is actually being emitted.

An apparatus for treating the skin of a patient by means of light therapy. The apparatus includes a base, a light emitting surface, moving means, and control means. The light emitting surface includes an array of light emitting sources, each source being configured for emitting different rays of light at different wavelengths. The moving means are used for controllably and remotely moving the light emitting surface with respect of the base along a predetermined path and at a predetermined rate. The control means are used for controlling the light emitting sources so that each source emits a given ray of light at a given wavelength, and for controlling the moving means so that the light emitting surface is moved to treat the skin of a patient. Also described is an assembly including the apparatus, as well as a method of operating the same.

The invention relates to the field of the medical apparatus and instruments, it is a pipeline bracket which can bearing micro radiation particle resource, and it mainly used in the treatment of pancreatic cancer or bile duct cancer in the metaphase or late stage. It also has the function of conduction consisting of the drainage tube 1 and the face to face bards 2 mounted on the two ends of the drainage tube. The inner cavity of the drainage tube is the drainage cavity 1.1, the particle duct 1.2 that its diameter matching with the outer diameter of the micro radiation particle resource is mounted in the tube wall. The irradiation window 1.3 of the micro radiation particle resource is equipped in the outer wall. The length and width of the irradiation window are on the small side of the micro radiation particle resource. The invention is simple in structure, and can be posted in vivo by endoscope via tiny wound, convenient to use and has the function of actinotherapy and conduction.

Described herein are the systems and methods of treating diseases related to fungal infection with light therapy. In one embodiment, an apparatus that utilizes one or multiple light emitting diodes (LED) to treat the fungus is applied externally to the infection area. Light therapy may applied periodically at scheduled times with continuous or pulsed radiation.

Systems and methods for providing light therapy traction to a patient. A light therapy device and a traction mechanism provide concurrent, alternating and / or repetitive treatment to a patient. The light therapy device includes one or more light sources configured to deliver light to a patient. The traction mechanism is configured to provide selective separation to a particular location the patient's body, such as a location of the patient's vertebrae. In some embodiments, the light therapy and traction are performed simultaneously. In other embodiments, the light therapy and lumbar traction are performed in treatment cycles to the patient. Embodiments of the present invention embrace the application of light therapy prior to, during, and / or after a cervical and / or lumbar traction treatment.

A drug, which can alleviate the side effect of actinotherapy and chemotherapy for the breast cancer, is the drug that is made from the raw materials of traditional Chinese herbal medicines, and the method of preparing for the drug is also provided. The traditional Chinese herbal medicines of a milkvetch root, a ginseng, a cooked rehmannia root, deer horn glue, tortoise glue, a tall gastrodis tuber, a dodder seed, a glossy privet fruit, a barbary wolfberry fruit, an achyranthes, an asarum, a cassia seed, a sun euphorbia, an olibanum gum a myrrh and a nuxvomica are used as the raw materials to be crushed and are concocted with honey as pills. During the courses of the actinotherapy and the chemotherapy, the drug of the invention can effectively improve the quantity of the leucocyte and platelet of the patient and can alleviate and even eliminate the adverse reaction during the courses of the actinotherapy and the chemotherapy to ensure the patient can finish the treatment.

The invention provides a method for inhibiting melatonin secretion by using a light source. According to the method, a lighting device is specially designed to emit lighting light having a specific wavelength within the wavelength range of 581nm and 590nm, and various experimental data have proved that the lighting light can be used to serve as a melatonin secretion inhibitor. Therefore, the experimental data have proved that the lighting device of the invention is suitable for being used for light therapy for winter depression, thereby treating the seasonal affective disorder (namely the winter depression) by inhibiting the melatonin secretion. Briefly speaking, after a patient suffering from the winter depression receives a treatment course of the light therapy with the lighting light with the wavelength range of 581-590nm, the symptoms of the winter depression, including somnolence, emotional disorder and the like, of the patient suffering from the winter depression can be cured finally due to the fact that the patient has a good mental state and a stable emotional state.

A multi-module therapeutic device for skincare comprises a housing capable of being ergonomically held in one hand, wherein a bottom surface of the housing is planar horizontal in shape, a plurality of Light Emitting Diodes (LEDs) configured to provide light therapy through the emission of electromagnetic radiation, a vibration motor configured to facilitate a provision of massage therapy, a metal sheet enclosed within the housing including a plurality of LED apertures for receiving the plurality of LEDs, wherein the metal sheet is configured to act as a medium for the application of massage therapy and thermotherapy, a medicament dispenser configured to dispense a medicament on actuation, and a control panel provided along a top surface of the housing, wherein the control panel is operably connected with the plurality of LEDs, the vibration motor, and the medicament dispenser.

A shaving device having a cutting head tuned for skin conditioning using light therapy. The cutting head of the shaving device includes a plurality of LED lights positioned around cutting blades which provide light therapy to the skin immediately after shaving using a range between 400 nm and 700 nm.

Methods and apparatuses for immunosuppression and / or immunomodulation for the treatment of an improper immune response with the use of UV light. In particular, described herein are methods and apparatuses for the treatment of inflammatory disorders using UVB light at appropriate intensities, durations and (internal) body regions in order to effect substantial and reliably treatment.

The invention discloses a polysaccharide nano composite material and preparation and application thereof, and belongs to the field of development and utilization of anti-tumor nano materials. The amphoteric self-assembled nano micelle entrapped photosensitizer zinc phthalocyanine overcomes the defect that zinc phthalocyanine is insoluble in water, targeting is performed through the EPR effect of the nano material. The tumor targeting property of the zinc phthalocyanine is improved. According to the invention, the limitation that zinc phthalocyanine is applied to the traditional light therapy is broken through, and the zinc phthalocyanine derivative has an obvious inhibition effect on B16 cells and is dose-dependent.

Provided are phototherapeutic needle patches usable for phototherapy by using needle patches capable of injecting drugs or cosmetic substances to patients, and methods of manufacturing the same. A phototherapeutic needle patch may include a patch body attachable to skin of a patient, at least one microneedle protruding from the patch body, one end of the microneedle configured to deliver a drug through stratum corneum of the skin to inner tissues of the skin, and light grooves formed in a concave shape along a length direction of the microneedle in such a manner that therapeutic light radiated from a light source for phototherapy easily penetrates into the skin along the microneedle.

The invention discloses a Chinese medicine preparation, especially a preparing method for an auxiliary medicine in treatment of leucopenia diseases. The main technology of the invention comprises: taking the tremella seed entity; making tremella polysaccharide dried paster by submerged fermentating, concentrating, ethanol eluting, separating and drying; smashing the dried paster; performing maturation and sterilization to obtain the powder of the invention, in which the powder can be put into capsules for the convenience in taking. The medicine in the invention achieves immunization stimulation function, can improve specific or non specific immunological reaction, and is used mainly for treating leucopenia caused by actinotherapy, chemotherapy or other reasons of tumor patient in clinic.

The invention discloses a multifunctional comprehensive diagnosis and treatment instrument. The multifunctional comprehensive diagnosis and treatment instrument comprises a patient functional state rapid diagnosis system, a scanner, a diagnosis and treatment bed / diagnosis and treatment chair, a laser treatment system, a terahertz treatment subsystem, an infrared treatment subsystem and a water laser treatment subsystem. Automatic control and reasonable diagnosis and treatment can be achieved, the scanner can adjust irradiation parts at will, accurate control is achieved, results are displayedon a screen, and an optimal treatment scheme can be conveniently made. The treatment system is formed by combining terahertz vibroflotation massage, laser vibration massage, magnetic laser, magnetic nozzle infrared modulation, fixed pulses and a helium-neon laser module. A new generation of terahertz, infrared and laser fusion medical diagnosis and treatment system achieves terahertz magnet therapy, infrared thermal therapy, laser therapy and water laser activation therapy by means of physical therapy and reflection therapy in practice, and has wide prospects in the field of life health diagnosis and treatment.

A face-wearable rhinitis treatment device using light therapy. The face-wearable rhinitis treatment device includes a light irradiating unit configured to irradiate light for rhinitis treatment into the nose of a patient; and a wearing main body, which is accommodated at positions spaced below the eyes of the patient and is wearable on the face of the patient. The face-wearable rhinitis treatment device may stably maintain the light irradiating unit for treating rhinitis at a correct position under the nose to improve treatment effect and may minimize restrictions of movement of the patient after wearing the face-wearable rhinitis treatment device to minimize discomfort of the patient.

Disclosures of the present invention describe a method for inhibiting melatonin secretion. In the present invention, an illumination device is particularly configured for emitting an illumination light with a specific wavelength that is in a range between 581 nm and 590 nm, and a variety of experimental data have proved that the illumination light functions as a melatonin secretion inhibitor. Therefore, the illumination device of the present invention is evidenced to be suitable for use in light therapy, so as to treat seasonal affective disorder (SAD) by way of inhibiting melatonin secretion. Briefly speaking, after a SAD patient receives the irradiation of the illumination light having wavelength ranged in 581-590 nm for a treatment course, the SAD patient is eventually leaded to stay in good spirits and a stable condition of emotion, thereby curing the abnormal symptoms of sleepiness and emotional disorder.

A prosthetic liner for use with a prosthetic socket that has a thermoplastic elastomeric (TPE) layer that is in contact with the amputee's residual limb. The TPE layer is not uniform in thickness but has ridges to extend circumferentially around the TPE layer. A fabric exterior layer covers the outer surface of the TPE layer conforming to the ridges and is used as a substrate to form a mechanical bond to an elastomeric material. Impregnating the elastomeric material within the fabric exterior occurs by applying an uncured material to the fabric exterior layer and onto at least the apex surfaces located within the sealing regions thereby creating an air tight boundary layer when inserted into a socket. When a vacuum is applied the air is evacuated from the volume below the seal layer.

Disclosed is an organic light-emitting device for light therapy for wound healing and cell proliferation, including: a substrate; an organic light-emitting device layer formed on the substrate and emitting red light; and a heat sink layer formed on the organic light-emitting device layer, which forms a red organic light-emitting device emitting red light in a stacking structure including a heat sink layer to generate light in a form of a planar light source which can be driven at a low temperature, thereby solving a problem of a burn and can perform light therapy through close contact with the skin.

Catheter-based systems for in-vivo targeted light therapy include a first type of catheter configured for photo-activating photosensitive substances in tissue, and a second type of catheter configured for photo-degrading photosensitive substances in tissue. The catheters may be configured to produce light using a variety of light sources, such as light emitting diodes (LEDs) and fiber optics. The light transmission is directed to tissue in such a way that only portions of tissue in a treatment area are exposed to light, depending upon whether the tissue is diseased or healthy.

A preparation and a method for inducing, enhancing or accelerating skin pigmentation for the therapy and / or prophylaxis of dichromic pathologies of the skin, the method comprising the application of a topical skin preparation containing NGF (Nerve Growth Factor), so as to obtain an intensification of the skin color of the re-pigmentation of de-pigmented epidermal areas following vitiligo or other hypopigmentary skin diseases. The preparation and related methods may also used in combination with other therapies known for the treatment of skin discoloration, such as the application of topical corticosteroids, activated vitamin D and / or activated D3, or phototherapy alone or in combination with photosensitizing agents, in particular psoralens.

The invention comprises componentry and devices for light therapy application to a patient in need thereof. The present invention relates to controllers for light therapy devices, light delivery elements, light guides, light guide arrangements configured to deliver personalized light therapy to one or more patients, with related componentry, dosage, and configurations of light therapy delivery elements (e.g., bandages, garments, braces, inserts etc.) suitable to deliver light therapy to one or more patient body areas and associated tissues, as well as sensors for monitoring treatment progress and dosage optimization. Methods of delivering light therapy to a patient and treatment of associated medical indications are also set out herein. Personalized LLLT dosage configurations and telemedicine LLLT treatment platforms and systems are also provided herein.

Methods for preventing or treating motor-related neurological conditions include using ocular light therapy in connection with a conventional therapy for a motor-related neurological condition, such as a drug regimen, to adjust levels of melatonin and / or dopamine in the body of a subject. The ocular light therapy may include elevated levels of blue-green light or green light (e.g., light within a wavelength range of 460 nm to 570 nm, 490 nm to 570 nm, about 520 nm to 570 nm, etc.). The ocular light therapy may also include reduced levels of amber, orange and / or red light. Methods for diagnosing motor-related neurological conditions include ocular administration of increased amounts of amber, orange and / or red light to cause a subject to temporarily exhibit one or more symptoms of any motor-related neurological condition to which the subject is predisposed, or which the subject may already be experiencing.

A method for treating autism. Light energy is applied externally to a patient's scalp on the skull near the frontal lobes. Optionally the light is also applied to the temporal lobes and the base of the brain. The treatment can be enhanced by activating the cranial nerves while the light is applied. In a preferred embodiment the applied light is in the red range and more preferably about of 635 nm±10 nm. In a preferred embodiment, the applied light energy is applied with a pulse frequency or frequencies of 8 Hz, 53 Hz, 73 Hz and 101 Hz. The light can be emitted from the same light emitter or from multiple emitters. Preferably the light is laser light and is emitted as a line from a hand-held laser device, and the line is waved manually across a person's skull in the desired area in a continuous, sweeping manner.

The invention relates to the technical field of medical instruments, and discloses a multifunctional phototherapy box. The multifunctional phototherapy box comprises a device body, wherein a sealing door is fixedly arranged on the surface of the device body; a door handle is fixedly arranged on the surface of the sealing door; an operation screen located on one side of the device body is fixedly arranged on the door handle; and a power line located on the other side of the device body is fixedly arranged on the operation screen. Skin diseases are treated through phototherapy, and drug treatment is not needed; an infrared lamp tube, an ultraviolet lamp tube and a blue lamp tube are arranged on the phototherapy instrument, and the phototherapy instrument can be put into use by turning on thelight required for the diseases of a patient through the operation screen; the used light is turned on through the operation screen, and meanwhile, a motor is started; the patient only needs to standinside the box body, and the phototherapy instrument is driven by a crawler-type motor to carry out comprehensive scanning treatment; and the box body adopts double-layer aluminum alloy for instrument isolation, so that the problems of electric leakage and the like are avoided, and the practicability of the phototherapy box is greatly improved.